INFI
Infinity Pharmaceuticals, Inc.
INFI
INFI
Delisted
INFI was delisted on the 13th of September, 2023.
143 hedge funds and large institutions have $779M invested in Infinity Pharmaceuticals, Inc. in 2014 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 42 increasing their positions, 38 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
143
Holders Change
+25
Holders Change %
+21.19%
% of All Funds
3.82%
Holding in Top 10
4
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+300%
% of All Funds
0.11%
New
40
Increased
42
Reduced
38
Closed
13
Calls
$6.43M
Puts
$16.4M
Net Calls
-$9.99M
Net Calls Change
+$1.32M
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$12.9M |
| 2 |
OAM
Oxford Asset Management
Oxford,
United Kingdom
|
+$9.93M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$7.03M |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
+$6.97M |
| 5 |
NI
Numeric Investors
Boston,
Massachusetts
|
+$6.38M |
Top Sellers
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$22.8M |
| 2 |
HM
HealthCor Management
New York
|
-$15.8M |
| 3 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
-$8.02M |
| 4 |
Adage Capital Partners
Boston,
Massachusetts
|
-$7.6M |
| 5 |
BC
Broadfin Capital
New York
|
-$6.83M |
